Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised double blind study of losmapimod for neuropathic pain due to peripheral nerve injury
2009-010091-17Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neuralgia comparing Losmapimod with Placebo (2 arms). Primary endpoint: Change in average daily pain score from baseline to Week 4. Started Jun 2009; status: completed.
02
Drugs
losmapimod
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2009-010091-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010091-17.